BREAKING: WHO Suspends Trial Of Hydroxychloroquine As COVID-19 Treatment Over Safety Concerns

Posted by E.L.E.X on May 26 2020 under News

The World Health Organisation has suspended testing malaria drug, Hydroxychloroquine, in COVID-19 patients due to safety concerns.

WHO Director-General, Tedros Adhanom Ghebreyesus, in a virtual press conference on Monday, said the decision came after the publication last week of a study indicating that using the drug on COVID-19 patients could increase their likelihood of dying.

Hydroxycholoroquine has been touted by United States President, Donald Trump, and others as a possible treatment for the disease.

Trump had said he was taking the drug to help prevent infection.

“The executive group has implemented a temporary pause of the Hydroxychloroquine arm within the solidarity trial while the safety data is reviewed by the data safety monitoring board,” Ghebreyesus said.

YOU MAY ALSO LIKE

Photos of starved lions at zoos in Obafemi Awolowo University (OAU) and Univeristy of Ibadan (UI) has sparked a discussion (PHOTOS)

“Don’t Visit Me At The Villa For Sallah, Stay Away From Large Gatherings” – Buhari Warns

Dino Melaye Reacts To The “Faint Drama” Of The NDDC Acting Chairman, Pondei

FG Seeks COVID-19 Patients For Herbal Drug Trials (Read Details)

NLC gives President Buhari fresh ultimatum to sign new minimum wage bill into law

Comments

Add Comment

All fields are required!